FIELD: medicine, pharmaceutics.
SUBSTANCE: in formula 
(I) R represents (C1-C7)alkyl or (C2-C7)alkenyl, wherein R is substituted by one or more substitutes optionally specified in R1; wherein R1 represents cyano or (C1-C4)alkyl, (C6)cycloalkyl or (C6)aryl each of which may be optionally substituted by one or more substitutes optionally specified in R2, wherein R2 represents (C1-C4)alkyl or -COORc or =N-ORa, -NRaRb or =O; Ra and Rb independently represent (C1-C4)alkyl or (C6)aryl; Rc represents (C1-C4)alkyl. The invention also refers to a pharmaceutical composition containing the above compound.
EFFECT: invention refers to the compound of structural formula I, which can be used to prevent, treat or reduce an intensity of symptoms of a disease or condition susceptible to IL-8 keratinocyte release stimulation, susceptible to neutrophil oxidative burst stimulation or susceptible to necrosis induction.
24 cl, 121 ex
| Title | Year | Author | Number |
|---|---|---|---|
| INGENOL-3-ACYLATES III AND INGENOL-3-CARBAMATES | 2011 |
|
RU2572549C2 |
| 3-ACYLINGENOLES II | 2011 |
|
RU2575350C2 |
| SUBSTITUTED BENZOAZEPINES AS TOLL-LIKE RECEPTOR MODULATORS | 2010 |
|
RU2580320C2 |
| 1,2,4-TRIAZOLE DERIVATIVES AS SIGMA RECEPTOR INHBITORS | 2007 |
|
RU2451015C2 |
| SYNTHESIS OF RESORCYLIC ACID LACTONES USED AS THERAPEUTIC AGENTS | 2009 |
|
RU2534527C2 |
| DIARYL COMPOUNDS WITH BRIDGE BOND | 2002 |
|
RU2297409C2 |
| DERIVATIVES OF 2-SUBSTITUTED PHENYL-5,7-DIHYDROCARBYL-3,7-DIHYDROPYRROLO[2,3-d]PYRIMIDIN-4-ONES, THEIR PREPARING AND PHARMACEUTICAL USING | 2004 |
|
RU2323220C2 |
| METHOD OF PRODUCING INGENOL-3-ANGELATE | 2011 |
|
RU2586975C2 |
| METHOD OF PRODUCING, METHODS OF USING AND COMPOSITION OF CYCLOALKYLMETHYLAMINES | 2007 |
|
RU2462451C2 |
| PYRAZOLPYRIMIDINE COMPOUNDS JAK INHIBITORS AND METHODS | 2009 |
|
RU2539568C2 |
